PHARMAZEUTISCHE FORMULIERUNG MIT CICLESONID

European patent · EP3473255 · In force

Register entry

Publication number
EP3473255
Application number
EP18204242
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 18, 2013
Published
Apr 24, 2019
Granted
Jan 12, 2022
Protection ends at the latest
Dec 17, 2033
Next annual fee due
Dec 31, 2026
IPC classes
A61K 31/573 (2006.01)
A61K 9/00 (2006.01)
A61P 11/00 (2006.01)
A61K 47/02 (2006.01)
A61K 47/10 (2017.01)
A61K 9/08 (2006.01)
A61K 31/58 (2006.01)
Priority
EP 12199302 21.12.2012
EP 13190393 25.10.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  5. Nov 23, 2022

    Change

    Published in Swissreg on 23.11.2022

  6. Jan 12, 2022

    Granted

    Published in Swissreg on 12.01.2022

Parties

Holder

BOEHRINGER INGELHEIM VETMEDICA GMBH

Boehringer Ingelheim Vetmedica GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

HAUSMANN, Matthias

55216 INGELHEIM AM RHEIN, DE

AVEN, Michael

55216 INGELHEIM AM RHEIN, DE

LANG, Ingo

55216 INGELHEIM AM RHEIN, DE

LAMAR, Janine

55216 INGELHEIM AM RHEIN, DE

ALBRECHT, Balazs

55216 INGELHEIM AM RHEIN, DE

FRANZMANN, Benjamin

55216 INGELHEIM AM RHEIN, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.